Among the companies with shares expected to trade actively in Thursday's session are Raytheon Co. (RTN), Thermo Fisher Scienti-fic Inc. (TMO) and Alexion Pharmaceuticals Inc. (ALXN).

 

Raytheon on Thursday raised its full-year profit guidance, completing a clean sweep of improved outlooks among the largest U.S. military contractors, which have driven their share prices to record highs. Shares rose 2.63% to $138.90 in premarket trading.

 

Thermo Fisher Scientific edged its earnings guidance higher for the year after revenue rose 6.2% in the latest quarter, boosted by the company's recent acquisitions, as the lab-equipment company readies to buy FEI Co. Shares fell 0.57% to $158 premarket.

 

Alexion Pharmaceuticals reported that revenue increased but profit fell as the rare-drug market continues to ramp up sales of new drugs. Shares fell 0.6% to $129.00 premarket.

 

Dow Chemical Co. (DOW) reported revenue slid less than anticipated and earnings easily topped expectations in the latest quarter despite continued pricing and currency headwinds. Shares rose 0.69% to $54 premarket.

 

Oracle Corp. (ORCL) agreed to buy NetSuite Inc. (N) for $9.3 billion, bolstering the software maker's cloud-computing offerings as it races to catch up to rivals. Oracle shares rose 1.95% to $41.73 premarket. NetSuite shares rose 18% to $108.15 premarket.

 

Colgate-Palmolive Co. (CL) reported revenue slid more than expected in the most recent quarter as foreign currency headwinds dragged down results, particularly in Latin America.

 

ConocoPhillips (COP) said its second-quarter loss widened as revenue slumped amid the prolonged commodities downturn.

 

Hershey Co. (HSY) said Thursday that it swung to a profit and posted revenue gains in its latest quarter; however, it was hurt by lower-than-expected growth in its candy, mint and gum segment.

 

Celgene Corp. (CELG) bumped up its earnings forecast for the year after sales of its flagship drug unexpectedly picked up.

 

GNC Holdings Inc. (GNC) replaced its chief executive Thursday and suspended its earnings guidance as the health and wellness retailer works to turn itself around and continues a strategic review that could result in a sale of the company.

 

Mattress maker Tempur Sealy International Inc. (TPX) reported better-than-expected profit in the latest period, helped by climbing revenue amid lower overall expenses.

 

Spectrum Brands Holdings Inc. (SPB) posted better-than-expected earnings in the most recent quarter on continued strength in its hardware and home improvement, battery and home and garden segments.

 

Alcoa Inc. (AA) plans to cut the number of its publicly traded shares with a 1-for-3 reverse stock split, as the aluminum maker prepares to split into two companies. A special shareholder meeting is scheduled for Oct. 5.

 

AllianceBernstein LP (AB) said Wednesday that it won't pursue a deal to buy a fund from hedge fund firm Visium Asset Management LP.

 

Amgen Inc.'s (AMGN) second-quarter profit rose 13% on higher-than-expected revenue, which was again driven by sales of key drugs such as Enbrel.

 

Cheesecake Factory Inc. (CAKE) on Wednesday increased its stock-buyback plan, raised its dividend and posted better-than-expected profit for its latest quarter.

 

Facebook Inc. (FB) on Wednesday topped $2 billion in quarterly profit, six months after crossing the billion dollar mark for the first time, as the number of new users--and the ad dollars that follow them--surged in the second quarter.

 

Fortune Brands Home & Security Inc. (FBHS)--the maker of MasterBrand cabinets, Moen faucets and Master Lock security products--on Wednesday raised further its financial projections for the year as it reported another big increases in quarterly profit, tied to a strong market for home products.

 

GoPro Inc. (GPRO) swung to a second-quarter loss, its third consecutive loss, as revenue dropped in nearly half. Chief Executive Nick Woodman said the company expects to return to profitability in the holiday quarter with the release of its next flagship camera, the Hero5.

 

Discount deals company Groupon Inc. (GRPN) on Wednesday reported better-than-expected results, driven by North America, where it added more than 1 million customers and reported a 9% increase in local billings.

 

IAC/InterActiveCorp. (IAC), which last year spun off its dating websites as Match Group Inc., on Wednesday swung to a second-quarter loss as it wrote down the value of its publishing segment.

 

Legg Mason Inc.'s (LM) second-quarter profit tumbled by nearly two-thirds as skittish investors pulled money from stocks and alternative investments and as the asset manager booked merger-related charges.

 

Marriott International Inc.'s (MAR) second-quarter profit rose 2.9% as it nears the close of its pending deal for Starwood Hotels & Resorts Worldwide Inc.

 

McKesson Corp.'s (MCK) profit in the latest quarter fell 4%, reflecting a loss on the sale of a Brazilian business, but adjusted earnings increased as the drug wholesaler said results were consistent with expectations.

 

Mylan NV (MYL) has received U.S. regulatory approval for its roughly $7.2 billion purchase of Swedish rival Meda, conditioned on Mylan divesting itself of rights to two generic drugs. The Federal Trade Commission's approval was the last regulatory step needed to complete the Meda deal.

 

O'Reilly Automotive Inc. (ORLY) on Wednesday posted second-quarter profit above the company's estimates as same-store sales came in near the top of its quarterly guidance.

 

Pilgrim's Pride Corp. (PPC) on Wednesday reported another sharp drop in quarterly profit amid domestic weakness. Sales in the U.S., which account for the bulk of the company's business, fell 8.8% in the latest period.

 

Six Flags Entertainment Corp. (SIX) reported better-than-expected revenue in its latest quarter as the theme-park operator saw increased turnout and higher guest spending, highlighting consumers' willingness to spend on experiences over goods.

 

Taikang Life Insurance Co. has disclosed a 13.5% stake in Sotheby's (BID), citing a "positive view" of the auction company's prospects as well as potential interest in a board seat.

 

Teva Pharmaceutical Industries Ltd. (TEVA) on Wednesday won regulatory approval from the Federal Trade Commission for its acquisition of Allergan PLC's (AGN) generics business, conditioned upon Teva's divestiture of 75 drugs to rivals.

 

Vertex Pharmaceuticals Inc.'s (VRTX) second-quarter loss narrowed, as sales of its cystic fibrosis drugs continued to increase. The Boston-based biopharmaceutical company's top- and bottom-line results beat expectations.

 

Whole Foods Market Inc. (WFM) on Wednesday gave weak projections for the current quarter as it booked its fourth-consecutive decline in quarterly profit and a key sales metric.

 

Xilinx Inc.'s (XLNX) quarterly profit rose 10% as the programmable chip maker's newer products continued to drive sales.

 

Write to Chris Wack at chris.wack@wsj.com or Maria Armental at maria.armental@wsj.com

 

(END) Dow Jones Newswires

July 28, 2016 09:27 ET (13:27 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Celgene Charts.
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Celgene Charts.